Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George E Johnson

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
Mutagenesis|October 8, 2015
Genotoxicity of flubendazole and its metabolites in vitro and the impact of a new formulation on in vivo aneugenicityDavid J Tweats, George E Johnson, Ivan Scandale, et al.
Regulatory Toxicology and Pharmacology : RTP|October 7, 2023
Nitrosamine acceptable intakes should consider variation in molecular weight: The implication of stoichiometric DNA damageJonathan Fine, Leonardo Allain, Joerg Schlingemann, et al.
Mutagenesis|June 10, 2021
Empirical comparison of genotoxic potency estimations: the in vitro DNA-damage ToxTracker endpoints versus the in vivo micronucleus assayJohn W Wills, Elias Halkes-Wellstead, Huw D Summers, et al.
Environmental and Molecular Mutagenesis|September 26, 2017
Comparing BMD-derived genotoxic potency estimations across variants of the transgenic rodent gene mutation assayJohn W Wills, George E Johnson, Hannah L Battaion, et al.
Environmental and Molecular Mutagenesis|January 11, 2021
The use of benchmark dose uncertainty measurements for robust comparative potency analysesRyan P Wheeldon, Stephen D Dertinger, Steven M Bryce, et al.
Archives of Toxicology|January 3, 2025
Critical comparison of BMD and TD<sub>50</sub> methods for the calculation of acceptable intakes for N-nitroso compoundsRobert Thomas, David J Ponting, Andrew Thresher, et al.
Environmental and Molecular Mutagenesis|September 14, 2020
Genotoxicity as a toxicologically relevant endpoint to inform risk assessment: A case study with ethylene oxideBala Bhaskar Gollapudi, Steave Su, Abby A Li, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|November 13, 2010
N-methylpurine DNA glycosylase plays a pivotal role in the threshold response of ethyl methanesulfonate-induced chromosome damageZoulikha M Zaïr, Gareth J Jenkins, Shareen H Doak, et al.
Environmental and Molecular Mutagenesis|January 27, 2020
Benchmark Dose Analysis of DNA Damage Biomarker Responses Provides Compound Potency and Adverse Outcome Pathway Information for the Topoisomerase II Inhibitor Class of CompoundsRyan P Wheeldon, Derek T Bernacki, Stephen D Dertinger, et al.
Mutagenesis|December 22, 2015
Empirical analysis of BMD metrics in genetic toxicology part I: in vitro analyses to provide robust potency rankings and support MOA determinationsJohn W Wills, George E Johnson, Shareen H Doak, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Mutagenesis|October 8, 2015
Genotoxicity of flubendazole and its metabolites in vitro and the impact of a new formulation on in vivo aneugenicityDavid J Tweats, George E Johnson, Ivan Scandale, et al.
Regulatory Toxicology and Pharmacology : RTP|October 7, 2023
Nitrosamine acceptable intakes should consider variation in molecular weight: The implication of stoichiometric DNA damageJonathan Fine, Leonardo Allain, Joerg Schlingemann, et al.
Mutagenesis|June 10, 2021
Empirical comparison of genotoxic potency estimations: the in vitro DNA-damage ToxTracker endpoints versus the in vivo micronucleus assayJohn W Wills, Elias Halkes-Wellstead, Huw D Summers, et al.
Environmental and Molecular Mutagenesis|September 26, 2017
Comparing BMD-derived genotoxic potency estimations across variants of the transgenic rodent gene mutation assayJohn W Wills, George E Johnson, Hannah L Battaion, et al.
Environmental and Molecular Mutagenesis|January 11, 2021
The use of benchmark dose uncertainty measurements for robust comparative potency analysesRyan P Wheeldon, Stephen D Dertinger, Steven M Bryce, et al.
Archives of Toxicology|January 3, 2025
Critical comparison of BMD and TD<sub>50</sub> methods for the calculation of acceptable intakes for N-nitroso compoundsRobert Thomas, David J Ponting, Andrew Thresher, et al.
Environmental and Molecular Mutagenesis|September 14, 2020
Genotoxicity as a toxicologically relevant endpoint to inform risk assessment: A case study with ethylene oxideBala Bhaskar Gollapudi, Steave Su, Abby A Li, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|November 13, 2010
N-methylpurine DNA glycosylase plays a pivotal role in the threshold response of ethyl methanesulfonate-induced chromosome damageZoulikha M Zaïr, Gareth J Jenkins, Shareen H Doak, et al.
Environmental and Molecular Mutagenesis|January 27, 2020
Benchmark Dose Analysis of DNA Damage Biomarker Responses Provides Compound Potency and Adverse Outcome Pathway Information for the Topoisomerase II Inhibitor Class of CompoundsRyan P Wheeldon, Derek T Bernacki, Stephen D Dertinger, et al.
Mutagenesis|December 22, 2015
Empirical analysis of BMD metrics in genetic toxicology part I: in vitro analyses to provide robust potency rankings and support MOA determinationsJohn W Wills, George E Johnson, Shareen H Doak, et al.
Pageof 7